Prediction of histologic differentiation grade of hepatocellular carcinoma by magnetic resonance imaging with hepatospecific contrast agent
暂无分享,去创建一个
Haoran Sun | Zhen Xu | X. Yang | X. Wang | Y. Wang | L. Hu | Q. Zeng | G. Li | H. Shi | T. Li | Y. Wang
[1] M. Okada,et al. Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma , 2020, Diagnostics.
[2] Yuyang Jiang,et al. Current discovery strategies for hepatocellular carcinoma therapeutics , 2019, Expert opinion on drug discovery.
[3] Qiang Liu,et al. Understanding the Global Cancer Statistics 2018: implications for cancer control , 2019, Science China Life Sciences.
[4] Chenyu Song,et al. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation , 2019, BMC Cancer.
[5] A. Luciani,et al. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio , 2019, European Radiology.
[6] T. Pawlik,et al. A wide‐margin liver resection improves long‐term outcomes for patients with HBV‐related hepatocellular carcinoma with microvascular invasion☆ , 2019, Surgery.
[7] L. Roberts,et al. Molecular and cellular oncogenic mechanisms in hepatocellular carcinoma. , 2018, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[8] A. Luciani,et al. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions , 2018, European Radiology.
[9] D. Cao,et al. Hepatocellular Carcinoma: Retrospective Evaluation of the Correlation Between Gadobenate Dimeglumine–Enhanced Magnetic Resonance Imaging and Pathologic Grade , 2018, Journal of computer assisted tomography.
[10] M. Mazurowski,et al. Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma. , 2018, AJR. American journal of roentgenology.
[11] M. Kanda,et al. Emerging evidence of molecular biomarkers in hepatocellular carcinoma. , 2018, Histology and histopathology.
[12] U. Tateishi,et al. Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study. , 2018, The British journal of radiology.
[13] K. Cortis,et al. Incorporating the hepatobiliary phase of gadobenate dimeglumine-enhanced MRI in the diagnosis of hepatocellular carcinoma: increasing the sensitivity without compromising specificity , 2016, Acta radiologica.
[14] D. Lu,et al. Gadoxetate Disodium-Enhanced MRI to Differentiate Dysplastic Nodules and Grade of Hepatocellular Carcinoma: Correlation With Histopathology. , 2015, AJR. American journal of roentgenology.
[15] R. Cabrera,et al. Current and future treatments for hepatocellular carcinoma. , 2015, World journal of gastroenterology.
[16] M. Imbriaco,et al. Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review , 2015, La radiologia medica.
[17] W. Guo,et al. Histological grade of hepatocellular carcinoma predicted by quantitative diffusion-weighted imaging. , 2015, International journal of clinical and experimental medicine.
[18] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[19] B. Taouli,et al. Hepatocellular carcinoma: Short‐term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T , 2015, Journal of magnetic resonance imaging : JMRI.
[20] B. Choi,et al. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. , 2014, Radiology.
[21] Ting-An Chang,et al. Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging. , 2013, World journal of gastroenterology.
[22] U. Motosugi,et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. , 2011, Radiology.
[23] F. Akisik,et al. Does the hepatocellular phase of gadobenate dimeglumine help to differentiate hepatocellular carcinoma in cirrhotic patients according to histological grade? , 2011, Clinical radiology.
[24] D. Choi,et al. Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced MRI versus Gadobenate Dimeglumine (Gd-BOPTA)-Enhanced MRI for Preoperatively Detecting Hepatocellular Carcinoma: an Initial Experience , 2010, Korean journal of radiology.
[25] W. Lau,et al. Partial Hepatectomy With Wide Versus Narrow Resection Margin for Solitary Hepatocellular Carcinoma: A Prospective Randomized Trial , 2007, Annals of surgery.
[26] W. Coleman,et al. Mechanisms of human hepatocarcinogenesis. , 2003, Current molecular medicine.
[27] H. Edmondson,et al. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.
[28] H. Honda,et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. , 2008, AJR. American journal of roentgenology.
[29] S. Arii,et al. Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. , 2004, Journal of hepatology.
[30] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.